Quest Diagnostics (DGX) Minority Interest (2009 - 2026)

Quest Diagnostics has reported Minority Interest for 18 years, with the latest figure at $303.0 million in Q2 2026.

• Quarterly Minority Interest rose 274.07% year-over-year to $303.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $303.0 million (up 274.07% YoY) and the FY2025 annual result came in at $80.0 million, down 3.61% from the prior year.
• Minority Interest grew to $303.0 million in Q2 2026 per DGX's latest filing, from $300.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $303.0 million in Q2 2026 and troughed at $76.0 million in Q3 2023.
• A 5-year average of $103.3 million and a median of $78.5 million in 2022 frame the typical range for Minority Interest.
• The sharpest annual moves came in 2025 and 2026: Minority Interest dropped 3.61% in 2025, then jumped 274.07% in 2026.
• Over 5 years, Minority Interest stood at $77.0 million in 2022, then declined by 1.3% to $76.0 million in 2023, then advanced by 9.21% to $83.0 million in 2024, then dropped by 3.61% to $80.0 million in 2025, then soared by 278.75% to $303.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $303.0 million, $300.0 million, and $80.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.